Minimally invasive versus open pancreatoduodenectomy (LEOPARD-2): study protocol for a randomized controlled trial
Authors:
- for the Dutch Pancreatic Cancer GroupFGfor the Dutch Pancreatic Cancer Group
- Thijs de RooijTRThijs de Rooij
- Jony van HilstJHJony van Hilst
- Koop BosschaKBKoop Bosscha
- Marcel G. DijkgraafMDMarcel G. Dijkgraaf
- Michael F. GerhardsMGMichael F. Gerhards
- Bas Groot KoerkampBKBas Groot Koerkamp
- Jeroen HagendoornJHJeroen Hagendoorn
- Ignace H. de HinghIHIgnace H. de Hingh
- Tom M. KarstenTKTom M. Karsten
- Daan J. LipsDLDaan J. Lips
- Misha D. LuyerMisha D. Luyer
Top Cited Papers
Open Access
- 3 January 2018
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 19 (1) , 1-10
Abstract
Data from observational studies suggest that minimally invasive pancreatoduodenectomy (MIPD) is superior to open pancreatoduodenectomy regarding intraoperative blood loss, postoperative morbidity, and length of hospital stay, without increasing total costs. However, several case-matched studies failed to demonstrate superiority of MIPD, and large registry studies from the USA even suggested increased mortality for MIPDs performed in low-volume (<10 MIPDs annually) centers. Randomized controlled multicenter trials are lacking but clearly required. We hypothesize that time to functional recovery is shorter after MIPD compared with open pancreatoduodenectomy, even in an enhanced recovery setting. LEOPARD-2 is a randomized controlled, parallel-group, patient-blinded, multicenter, phase 2/3, superiority trial in centers that completed the Dutch Pancreatic Cancer Group LAELAPS-2 training program for laparoscopic pancreatoduodenectomy or LAELAPS-3 training program for robot-assisted pancreatoduodenectomy and have performed ≥ 20 MIPDs. A total of 136 patients with symptomatic benign, premalignant, or malignant disease will be randomly assigned to undergo minimally invasive or open pancreatoduodenectomy in an enhanced recovery setting. After the first 40 patients (phase 2), the data safety monitoring board will assess safety outcomes (not blinded for treatment allocation) and decide on continuation to phase 3. Patients from phase 2 will then be included in phase 3. The primary outcome measure is time (days) to functional recovery. All patients will be blinded for the surgical approach, at least until postoperative day 5, but preferably until functional recovery has been attained. Secondary outcome measures are operative and postoperative outcomes, including clinically relevant complications, mortality, quality of life, and costs. The LEOPARD-2 trial is designed to assess whether MIPD reduces time to functional recovery, as compared with open pancreatoduodenectomy in an enhanced recovery setting. Netherlands Trial Register, NTR5689 . Registered on 2 March 2016.Keywords
Funding Information
- Ethicon Endo-Surgery (IIS 15-707)
This publication has 36 references indexed in Scilit:
- IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stageBMJ, 2013
- Open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS® programme (ORANGE II – Trial): study protocol for a randomised controlled trialTrials, 2012
- Technical Aspects of Robotic-Assisted Pancreaticoduodenectomy (RAPD)Journal of Gastrointestinal Surgery, 2011
- Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver SurgerySurgery, 2011
- Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)Surgery, 2007
- Postpancreatectomy hemorrhage (PPH)–An International Study Group of Pancreatic Surgery (ISGPS) definitionSurgery, 2007
- Postoperative pancreatic fistula: An international study group (ISGPF) definitionSurgery, 2005
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Guideline for Prevention of Surgical Site Infection, 1999American Journal of Infection Control, 1999
- Laparoscopic pylorus-preserving pancreatoduodenectomySurgical Endoscopy, 1994